Kate Therapeutics
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
$51M Series A ·
Led by Versant Ventures · Source: fundraisingfox.com
Funding history ↓Signals
Website registeredSep 5, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $51M | fundraisingfox.com |
Timeline
- Website created
Founders and team
KF
Kevin Forrest FounderMF
Mark Fielden FounderST
Sharif Tabebordbar Founder
Investors
OOUP (Osage University Partners)
UUF Innovate Ventures
VVersant Ventureslead investor
WWestlake Village BioPartnerslead investor
Companies like Kate Therapeutics
EEvolyra TherapeuticsSeed · Apr 2026
AAddition Therapeutics$100M Series A · Dec 2025
AAlia Therapeutics$5M Seed · Apr 2023BBrano Therapeutics$6.8M Seed · May 2026
TTune Therapeutics$175M Series B+ · Jan 2025
EEngimmune Therapeutics$16M Seed · May 2022
Other companies backed by Versant Ventures
NNouscom$135.04M Series B+ · Oct 2026
MMonteris Medical$28M Series B+ · Mar 2026
GGranite Bio$30M Series A · Apr 2025
JJnana Therapeutics$107M Series B+ · Nov 2022
TT-Knife$110M Series B+ · Aug 2021
BBright Peak TherapeuticsSeries B+ · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kate-therapeutics (get a free API key).